TITLE

Severe sepsis in a premature neonate: protein C replacement therapy

AUTHOR(S)
De Carolis, Maria Pia; Polimeni, Valentina; Papacci, Patrizia; Lacerenza, Serafina; Romagnoli, Costantino
PUB. DATE
July 2008
SOURCE
Turkish Journal of Pediatrics;2008, Vol. 50 Issue 4, p405
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Treatment with activated protein C has been shown to reduce mortality in adult patients with severe sepsis but also to increase risk of bleeding. In patients with predisposition to bleeding, as in preterm infants, the inactivated form of protein C could serve as a safe therapeutic option. We report the case of a preterm neonate who developed severe sepsis on the 28th day of life, who was successfully treated with the inactivated form of protein C for a period of 96 hours.
ACCESSION #
35401368

 

Related Articles

  • Risks and Benefits of Activated Protein C Treatment for Severe Sepsis. Warren, H. Shaw; Suffredini, Anthony F.; Eichacker, Peter Q.; Munford, Robert S. // New England Journal of Medicine;9/26/2002, Vol. 347 Issue 13, p1027 

    Discusses the risks and benefits of activated protein C treatment for severe sepsis. The two phases of the activated protein C trial; Subgroups and restrictions to use in high-risk patients; The risk of serious hemorrhage; The conclusion that activated C is effective with some patients.

  • Prevalence of Serious Bleeding Events and Intracranial Hemorrhage in Patients Receiving Activated Protein C: A Systematic Review and Meta-analysis. Khan, Ajmal; Agarwal, Ritesh; Aggarwal, Ashutosh N.; Gupta, Dheeraj // Respiratory Care;Jul2010, Vol. 55 Issue 7, p901 

    BACKGROUND: Activated protein C reduces 28-day mortality in patients with severe sepsis, but its anticoagulant properties entail a risk of bleeding. OBJECTIVE: The aim of this systematic review was to evaluate the prevalence of serious bleeding events in patients receiving activated protein C....

  • Intraventricular haemorrhage in prematurity. Pettorini, Benedatta; Keh, Ryan; Ellenbogen, Jonathan; Williams, Dawn; Zebian, Bassel // Infant;Nov2014, Vol. 10 Issue 6, p186 

    No abstract available.

  • Erratum to: Time intervals from aneurysmal subarachnoid hemorrhage to treatment and factors contributing to delay. Germans, Menno; Hoogmoed, Jantien; Straaten, H.; Coert, Bert; Peter Vandertop, W.; Verbaan, Dagmar // Journal of Neurology;Sep2014, Vol. 261 Issue 9, p1850 

    A correction to the article "Time intervals from aneurysmal subarchnoid hemorrhage to treatment and factors contributing to delay," by Menno Robbert Germans and colleagues that was published in the August 7, 2014 issue is presented.

  • Risk Factors of Germinal Matrix Intraventricular Hemorrhage in Premature Infants. Pekcevik, Yeliz; Pasinli, Aynur; Ozer, Esra Arun; Erdogan, Nuri // Iranian Journal of Pediatrics;Apr2014, Vol. 24 Issue 2, p191 

    Objective: To determine whether some clinical parameters can be used to predict the hemorrhage and whether the relationship between these clinical variables and the grades of hemorrhage is linear. Methods: A total of 230 premature infants, born at a gestational age less than 34 weeks were...

  • Ciprofloxacin appears safe for newborn septicaemia.  // Reactions Weekly;1/20/2007, Issue 1135, p3 

    The article discusses research being done on the safety of treatment with ciprofloxacin to preterm neonates suffering from septicemia. It references a study by N. Z. Khan et al published in the December 2006 issue of the "Pediatric Infectious Disease Journal." Normal physical examination was...

  • Early cystic lung disease in a premature neonate with perinatally acquired capnocytophaga. Howlett, A. A.; Mailman, T. L.; Ganapathy, V. // Journal of Perinatology;Jan2007, Vol. 27 Issue 1, p68 

    We describe a premature infant with early cystic lung lesions and sepsis due to prenatally acquired Capnocytophaga infection. Early cystic lesions have not been described previously as a characteristic of this infection.Journal of Perinatology (2007) 27, 68–70. doi:10.1038/sj.jp.7211627

  • Bilateral endogenous endophthalmitis as a complication of late-onset sepsis in a premature infant. Matasova, Katarina; Hudecova, Janka; Zibolen, Mirko // European Journal of Pediatrics;2003, Vol. 162 Issue 5, p346 

    Discusses bilateral endogenous endophthalmitis as a complication of late-onset sepsis in a premature infant. Family history of the infant who was delivered by caeserean section in the 30th week of gestation; Reasons for which he was delivered through caeserean case; Information on the invasive...

  • Dexamethasone Therapy and Candida Sepsis in Neonates Less Than 1250 Grams. Pera, Angelina; Byun, Angela; Gribar, Steven; Schwartz, Rama; Kumar, Deepak; Parimi, Prabhu // Journal of Perinatology;Apr2002, Vol. 22 Issue 3, p204 

    OBJECTIVE: To determine whether dexamethasone use increases the risk for Candida sepsis (CS) in very low birth weight premature infants (< 1250 g). DESIGN: Retrospective chart review of all infants with a birth weight < 1250 g, admitted to the neonatal intensive care unit of the MetroHealth...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics